Garuda Therapeutics has filed a notice of an exempt offering of securities to raise $62,898,094.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Garuda Therapeutics is raising $62,898,094.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Dhvanit Shah played a key role in…
